Biotest Pharmaceuticals Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$811,134
Doctors Paid
7
Transactions
114
2017 Total
$811,134
Payment Breakdown by Category
Research$810,921 (100.0%)
Food & Beverage$213.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $810,921 | 112 | 100.0% |
| Food and Beverage | $213.03 | 2 | 0.0% |
Payments by Type
Research
$810,921
112 transactions
General
$213.03
2 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase I/IIa Multi-dose Escalation Study of BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Subjects With Relapsed or Relapsed/Refractory Multiple Myeloma | $474,334 | 3 | 44 |
| A Phase IV, Multicenter, Open-label Study to Evaluate the Safety and Pharmacokinetics of BIVIGAM in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16 | $229,997 | 3 | 25 |
| A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion (Pass 17) | $103,065 | 0 | 41 |
| A Phase I/IIa Multi-Dose Escalation Study to Evaluate Maximum Tolerated Dose (MTD), Pharmacokinetics (PK), Safety and Efficacy of BT062 in Subjects With Relapsed or Relapsed/Refractory Multiple Myeloma | $3,525 | 1 | 2 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Internal Medicine | $5,200 | 1 | $5,200 |
| Dermatology | $3,000 | 1 | $3,000 |
| Gastroenterology | $1,750 | 1 | $1,750 |
| Allergy & Immunology | $213.03 | 1 | $213.03 |
| Rheumatology | $50.00 | 1 | $50.00 |
| Pediatric Hematology-Oncology | $36.99 | 1 | $36.99 |
| Pediatric Critical Care Medicine | $36.66 | 1 | $36.66 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| John Leonard, Md, MD | Internal Medicine | New York, NY | $5,200 | $0 |
| Dr. Jennifer Choi, M.d, M.D | Dermatology | Chicago, IL | $3,000 | $0 |
| Dr. John Birk, M.d, M.D | Gastroenterology | Farmington, CT | $1,750 | $0 |
| Richard Wasserman, Md, Phd, MD, PHD | Allergy & Immunology | Dallas, TX | $213.03 | $0 |
| Atul Khasnis, M.d, M.D | Rheumatology | Tyrone, GA | $50.00 | $0 |
| Dr. Garrett Bergman, M.d, M.D | Pediatric Hematology-Oncology | Narberth, PA | $36.99 | $0 |
| Utpal Bhalala, Md, MD | Pediatric Critical Care Medicine | San Antonio, TX | $36.66 | $0 |
Ad
Top Products
- BT062 $477,859
- Bivigam $333,062
Payment Categories
- Food & Beverage $213.03
- Research $810,921
About Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals Corporation has made $811,134 in payments to 7 healthcare providers, recorded across 114 transactions in the CMS Open Payments database. In 2017, the company paid $811,134. The top product by payment volume is BT062 ($477,859).
Payments were distributed across 7 medical specialties. The top specialty by payment amount is Internal Medicine ($5,200 to 1 doctors).
Payment categories include: Food & Beverage ($213.03), Research ($810,921).